Literature DB >> 2764551

Antibiotic treatment of enterococcal infection.

J M Hamilton-Miller.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2764551      PMCID: PMC284273          DOI: 10.1128/AAC.33.6.989

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  10 in total

1.  Enterococci and antifolate antibiotics.

Authors:  J M Hamilton-Miller; D Purves
Journal:  Eur J Clin Microbiol       Date:  1986-08       Impact factor: 3.267

2.  Serious infection due to beta-lactamase-producing Streptococcus faecalis with high-level resistance to gentamicin.

Authors:  J E Patterson; S M Colodny; M J Zervos
Journal:  J Infect Dis       Date:  1988-11       Impact factor: 5.226

3.  Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium.

Authors:  R Leclercq; E Derlot; J Duval; P Courvalin
Journal:  N Engl J Med       Date:  1988-07-21       Impact factor: 91.245

Review 4.  The enterococcus: "putting the bug in our ears".

Authors:  S A Hoffmann; R C Moellering
Journal:  Ann Intern Med       Date:  1987-05       Impact factor: 25.391

5.  Reversal of activity of trimethoprim against gram-positive cocci by thymidine, thymine and 'folates'.

Authors:  J M Hamilton-Miller
Journal:  J Antimicrob Chemother       Date:  1988-07       Impact factor: 5.790

6.  Trimethoprim resistance in enterococci: microbiological and biochemical aspects.

Authors:  J M Hamilton-Miller; S Stewart
Journal:  Microbios       Date:  1988

Review 7.  Enterococcal bacteremia: clinical features, the risk of endocarditis, and management.

Authors:  D G Maki; W A Agger
Journal:  Medicine (Baltimore)       Date:  1988-07       Impact factor: 1.889

8.  Trimethoprim resistance and trimethoprim usage in and around The Royal Free Hospital in 1985.

Authors:  J M Hamilton-Miller; D Purves
Journal:  J Antimicrob Chemother       Date:  1986-11       Impact factor: 5.790

9.  Susceptibility of enterococci to trimethoprim and trimethoprim-sulfamethoxazole.

Authors:  S R Crider; S D Colby
Journal:  Antimicrob Agents Chemother       Date:  1985-01       Impact factor: 5.191

10.  In vivo v in vitro susceptibility of enterococcus to trimethoprim-sulfamethoxazole. A pitfall.

Authors:  G L Goodhart
Journal:  JAMA       Date:  1984-11-16       Impact factor: 56.272

  10 in total
  1 in total

Review 1.  Screening and treatment of infections caused by resistant enterococci.

Authors:  D J Herman; D N Gerding
Journal:  Antimicrob Agents Chemother       Date:  1991-02       Impact factor: 5.191

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.